Evidence map›Paper›PMID 41823454›Full record

ArticleApplied and environmental microbiology2026

Genetic modification of

Caroline Schlaiß, Saskia T Baur, James W Marsh, Kurt Gemeinhardt, Largus T Angenent

Abstract read
In one paragraph

Article in Applied and environmental microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Caroline SchlaißAG Angenent, Max Planck Institute for Biology, Tübingen, Germany.
Saskia T BaurEnvironmental Biotechnology Group, Department of Geosciences, University of Tübingen, Tübingen, Germany.ORCID 0000-0002-7186-9163
James W MarshDepartment of Microbiome Science, Max Planck Institute for Biology, Tübingen, Germany.
Kurt GemeinhardtEnvironmental Biotechnology Group, Department of Geosciences, University of Tübingen, Tübingen, Germany.
Largus T AngenentAG Angenent, Max Planck Institute for Biology, Tübingen, Germany.ORCID 0000-0003-0180-1865

Funding

Alexander von Humboldt-Stiftung Humboldt ProfessorDeutsche Forschungsgemeinschaft EXC 2124 - 390838134Deutsche Forschungsgemeinschaft Leibniz PrizeMax Planck Institute for Biology Max Planck FellowNovo Nordisk Fonden NNF21SA0072700
6 · The paper itself

Abstract

The mesophilic microbe IMPORTANCE: Medium-chain carboxylates are required in various everyday products, including cosmetics, pharmaceuticals, and fragrances, and show a natural antimicrobial property. Furthermore, they represent food additives and serve as chemical building blocks for several other compounds. Traditionally, these carboxylates are produced from fossil resources, contributing to increased greenhouse gas emissions. Alternatively, they are derived from animal- or plant-based fat (e.g., coconut oil), which competes with agricultural land that is needed for food production. However, microbial chain elongation, which is a biotechnological approach relying on microbes, such as

Indexed as

1-ButanolClostridium kluyveriHexanolsAlcohol DehydrogenaseBacterial ProteinsClostridium acetobutylicumMetabolic EngineeringMethyltransferasesPlasmids1-Butanol1-hexanolAlcohol DehydrogenaseBacterial ProteinsHexanolsMethyltransferaseschain elongationClostridium kluyverimetabolic engineeringn-caproaten-hexanol

Identifiers

PMID41823454
PMCPMC13101501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.